NEONATAL PULMONARY HYPERTENSION

NEONATAL PULMONARY HYPERTENSION was reported 38 times

NEONATAL PULMONARY HYPERTENSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 2 0.0004
1 Human Immunoglobulin G [EPC] 2 0.0001
2 Penem Antibacterial [EPC] 1 0.0000
3 Macrolide Antimicrobial [EPC] 1 0.0000
4 Glycopeptide Antibacterial [EPC] 1 0.0000
5 Catecholamine [EPC] 1 0.0000
6 Partial Opioid Agonist [EPC] 1 0.0000
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
8 Purine Antimetabolite [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 12 0.0000
10 Opioid Agonist [EPC] 2 0.0000
11 Azole Antifungal [EPC] 1 0.0000
12 Microtubule Inhibitor [EPC] 1 0.0000
13 Benzodiazepine [EPC] 4 0.0000
14 Interferon beta [EPC] 1 0.0000
15 Alkylating Drug [EPC] 1 0.0000
16 Platinum-based Drug [EPC] 1 0.0000
17 Factor Xa Inhibitor [EPC] 1 0.0000
18 Platelet Aggregation Inhibitor [EPC] 2 0.0000
19 Atypical Antipsychotic [EPC] 1 0.0000
20 Corticosteroid [EPC] 2 0.0000